EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial

Ashis Samuel John iD, Sanjay Ganapathi iD, Sivadasanpillai Harikrishnan iD, Thoniparambil Ravindranathanpillai Lekha, Antony Stanley iD, Biju Soman iD, Thekkumkara Surendran Anish iD, Rujuta Hadaye iD, Jerin Jose Cherian iD, Nikhil Tandon iD, Dorairaj Prabhakaran iD, Panniyammakal Jeemon iD

Global Heart · 31.07.2025 · 20 (1) · 65

DOI: 10.5334/gh.1450 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Global Heart, online erschienen am 31.07.2025. Verfasst von Ashis Samuel John und 11 weiteren Autor:innen. Beteiligte Einrichtung: Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Life Style, Risk Reduction Behavior. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NHLBI NIH HHS, Wellcome Trust/DBT India Alliance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We performed a within-trial cost-effectiveness analysis of a targeted family-based structured lifestyle modification intervention for cardiovascular risk reduction. Research design and methods: The PROLIFIC study was an open-label, cluster randomised controlled trial in the families (first-degree relatives and spouses older than age 18 years) of individuals with premature coronary heart disease. Families in the intervention group received a comprehensive package of interventions facilitated by non-physician health workers: screening for cardiovascular risk factors, structured lifestyle interventions, linkage to a primary healthcare facility for individuals with established chronic disease risk factors or conditions, and active follow-up for adherence. The usual care group received one-time counselling and annual screening for risk factors. The cost was estimated from a health system perspective, including intervention and treatment costs. Effectiveness was measured as changes in risk factors and quality-adjusted life years (QALYs) elicited using the EQ-5D-5 L instrument. The time horizon was two years, and we performed one-way and probabilistic sensitivity analyses.

Results

Over two years, the incremental cost for the intervention compared to usual care was Int$ 157.5 per person (intervention group: Int$ 381.6, usual care group: Int$ 224.1), and the incremental QALY gain was 0.014 (0.0166 Vs 0.0027). The within-trial ICER was 11,352 Int$/QALY. Incremental cost per unit reduction in systolic blood pressure, fasting plasma glucose, HbA1c, total cholesterol, and waist circumference were Int$ 28.5, 26.9, 130.8, 178.7, and 39.8, respectively.

Conclusions

A family-based structured lifestyle modification program yields a net gain in quality of life and is cost-effective at a three times gross domestic product per capita threshold. The intervention is expected to be relatively more cost-effective when scaled up to larger populations over longer time horizons. The intervention has the potential for a substantial public health impact if adopted as a strategy at the state or national level. Trial Registration Number: Clinicaltrials.gov, NCT02771873.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesLife StyleRisk Reduction BehaviorAdultFemaleHumansMaleMiddle AgedCost-Effectiveness AnalysisHeart Disease Risk FactorsQuality-Adjusted Life Years

Stichwörter der Autor:innen

Cost-effectiveness analysisIschemic heart diseaseLifestyle interventionPreventive cardiology

Autor:innen und Institutionen

  • Achutha Menon Centre for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
  • Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
  • Department of Community Medicine, Government Medical College Mananthavady, Wayanad, Kerala, India.
  • Department of Community Medicine, Topiwala National Medical College, Mumbai, India.
  • Division of Developmental Research, Indian Council of Medical Research, New Delhi, India.
  • Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.

ORCID-Profile: Ashis Samuel John, Sanjay Ganapathi, Sivadasanpillai Harikrishnan, Antony Stanley, Biju Soman, Thekkumkara Surendran Anish, Rujuta Hadaye, Jerin Jose Cherian, Nikhil Tandon, Dorairaj Prabhakaran, Panniyammakal Jeemon

Förderung

  • Wellcome Trust
  • NHLBI NIH HHS
  • Wellcome Trust/DBT India Alliance

Zitieren

APA

John, A. S., Ganapathi, S., Harikrishnan, S., Lekha, T. R., Stanley, A., Soman, B., Anish, T. S., Hadaye, R., Cherian, J. J., Tandon, N., Prabhakaran, D., & Jeemon, P. (2025). Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial. Global Heart, 20(1), 65. https://doi.org/10.5334/gh.1450

Vancouver

John AS, Ganapathi S, Harikrishnan S, Lekha TR, Stanley A, Soman B, et al. Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial. Global Heart. 2025;20(1):65. doi:10.5334/gh.1450

BibTeX
@article{John2025,
  author = {John, Ashis Samuel and Ganapathi, Sanjay and Harikrishnan, Sivadasanpillai and Lekha, Thoniparambil Ravindranathanpillai and Stanley, Antony and Soman, Biju and Anish, Thekkumkara Surendran and Hadaye, Rujuta and Cherian, Jerin Jose and Tandon, Nikhil and Prabhakaran, Dorairaj and Jeemon, Panniyammakal},
  title = {Within-Trial Cost-Effectiveness Analysis of a Family-Based Structured Lifestyle Modification Intervention Program for Cardiovascular Risk Reduction: Results from the PROLIFIC Trial},
  journal = {Global Heart},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {65},
  doi = {10.5334/gh.1450}
}
Kostenlos starten →